LiveWell Peptides makes no medical claims
The state of ketosis, induced by low insulin levels, may generally benefit cancer patients, as KBs have been shown to inhibit glycolysis in various tumor cell lines 73, 74 and probably also patients, 75, 76, 77 and tumor cells often lack the enzymes 78, 79, 80, 81 or oxygenation 82 to effectively use ketones for energy production
The combination of BPC-157, TB-500, KPV, and GHK-Cu enables investigation of pathway convergence, signaling overlap, and coordinated molecular responses within controlled experimental models
Hence, a part of the data is missing, and therefore, no statistical test was performed to evaluate the treatment effect